Screening for prostate cancer: what are the benefits ?

Article Sidebar

PDF
Published: Apr 15, 2012
DOI: https://doi.org/10.18051/UnivMed.2012.v31.1-3 Universa Medicina
Abstract Viewed: 244
PDF Downloaded: 60

Main Article Content

Murad Lesmana
Department of Microbiology Medical Faculty, Trisakti University

Abstract

In men of advanced age, the epithelial cells of the prostate gland undergo substantial stress-associated changes that may result in DNA damage. The aging prostate gland acquires several cancer cell foci originating from special clonal transformation. Most of these foci never develop into clinically detectable cancer.

Article Details

How to Cite
Lesmana, M. (2012). Screening for prostate cancer: what are the benefits ?. Universa Medicina, 31(1), 1–3. https://doi.org/10.18051/UnivMed.2012.v31.1-3
Issue
Vol. 31 No. 1 (2012)
Section
Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Gelmann EP. Complexities of prostate cancer risk. N Engl J Med 2008;358:961-3.

Carter H. Prostate cancers in men with low PSA levels – must we find them? N Engl J Med 2004;350: 2292-4.

U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:185-91.

Barry MJ. Screening for prostate cancer among men 75 years of age or older. N Engl J Med 2008;350:2515-6.

Schwarttz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-8.